A detailed history of Black Rock Inc. transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,360,093 shares of GLUE stock, worth $20 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,360,093
Previous 2,307,009 2.3%
Holding current value
$20 Million
Previous $16.3 Million 45.73%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.38 - $7.86 $179,423 - $417,240
53,084 Added 2.3%
2,360,093 $8.83 Million
Q1 2024

May 10, 2024

SELL
$4.26 - $8.46 $276,776 - $549,654
-64,971 Reduced 2.74%
2,307,009 $16.3 Million
Q4 2023

Feb 13, 2024

SELL
$2.5 - $5.93 $3.31 Million - $7.84 Million
-1,322,688 Reduced 35.8%
2,371,980 $13.4 Million
Q3 2023

Nov 13, 2023

SELL
$4.78 - $7.22 $791,988 - $1.2 Million
-165,688 Reduced 4.29%
3,694,668 $17.7 Million
Q2 2023

Aug 11, 2023

BUY
$4.53 - $8.4 $1.14 Million - $2.11 Million
250,935 Added 6.95%
3,860,356 $26.4 Million
Q1 2023

May 12, 2023

BUY
$5.95 - $8.21 $64,765 - $89,365
10,885 Added 0.3%
3,609,421 $28.1 Million
Q4 2022

Feb 13, 2023

BUY
$6.71 - $9.72 $860,919 - $1.25 Million
128,304 Added 3.7%
3,598,536 $27.4 Million
Q3 2022

Nov 14, 2022

BUY
$7.17 - $12.16 $1.13 Million - $1.92 Million
157,663 Added 4.76%
3,470,232 $28.4 Million
Q2 2022

Aug 12, 2022

BUY
$6.15 - $14.99 $1.13 Million - $2.76 Million
184,177 Added 5.89%
3,312,569 $32 Million
Q1 2022

May 12, 2022

BUY
$10.36 - $20.41 $8.03 Million - $15.8 Million
774,628 Added 32.91%
3,128,392 $43.9 Million
Q4 2021

Feb 10, 2022

BUY
$16.28 - $27.15 $4.64 Million - $7.74 Million
285,087 Added 13.78%
2,353,764 $48.1 Million
Q3 2021

Nov 09, 2021

BUY
$18.59 - $42.21 $9.64 Million - $21.9 Million
518,792 Added 33.47%
2,068,677 $46.1 Million
Q2 2021

Aug 11, 2021

BUY
$18.86 - $22.7 $29.2 Million - $35.2 Million
1,549,885 New
1,549,885 $35.2 Million

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $397M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.